Cells (Oct 2022)

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer

  • Annapaola Mariniello,
  • Fabrizio Tabbò,
  • Davide Indellicati,
  • Martina Tesauro,
  • Nicole Alessia Rezmives,
  • Maria Lucia Reale,
  • Angela Listì,
  • Enrica Capelletto,
  • Simona Carnio,
  • Valentina Bertaglia,
  • Caterina Mecca,
  • Lorena Consito,
  • Marco De Filippis,
  • Maristella Bungaro,
  • Chiara Paratore,
  • Massimo Di Maio,
  • Francesco Passiglia,
  • Luisella Righi,
  • Dario Sangiolo,
  • Silvia Novello,
  • Massimo Geuna,
  • Paolo Bironzo

DOI
https://doi.org/10.3390/cells11203226
Journal volume & issue
Vol. 11, no. 20
p. 3226

Abstract

Read online

Background: Lung cancer (LC) tissue for immunological characterization is often scarce. We explored and compared T cell characteristics between broncho-alveolar lavage from tumor affected (t-BAL) and contralateral lung (cl-BAL), with matched peripheral blood (PB). Methods: BAL and PB were collected during bronchoscopy for diagnostic and/or therapeutic purposes in patients with monolateral primary lesion. Results: Of 33 patients undergoing BAL and PB sampling, 21 had histologically-confirmed LC. Most cases were locally-advanced or metastatic non-small cell LC. T cell characteristics were not significantly different in t-BAL vs. cl-BAL. Compared to PB, CD8 T cells in BAL presented features of immune activation and exhaustion (high PD-1, low IFN-g production). Accordingly, regulatory CD4 T cells were also higher in BAL vs. PB. When dichotomizing T cell density in t-BAL in high and low, we found that PD-L1 expression in LC was associated with T cell density in t-BAL. T-BAL with high T cell density had higher %IFN-g+CD8 T cells and lower %T-regs. Conclusion: In BAL from advanced LC patients, T cells present features of exhaustion. T cells in t-BAL could be the best surrogate of tumor-infiltrating T cell, and future studies should evaluate T cell phenotype and density as potential biomarkers for cancer immunotherapy outcome.

Keywords